Recent trends: Medical management of infectious keratitis

Oman Journal of Ophthalmology

Volumn 8, Issue 2, 2015, Pages 83-85

  Solanki, Sneha ^a   Rathi, Manisha ^a   Khanduja, Sumeet ^a   Dhull, C S ^a   Sachdeva, Sumit ^a   Phogat, Jitender ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

collagen cross linking with riboflavin therapy; Corneal ulcer; fourth generation fluoroquinolones; Infectious keratitis

Indexed keywords

EID: 84934275924     PISSN: 0974620X     EISSN: 09747842     Source Type: Journal    
DOI: 10.4103/0974-620X.159104     Document Type: Review

References (23)

1. Gokhale NS. Medical management approach to infectious keratitis. Indian J Ophthalmol 2008;56:215-20
2. Gupta N, Tandon R. Investigative modalities in infectious keratitis. Indian J Ophthalmol 2008;56:209-13
3. Chew SJ, Beuerman RW, Assouline M, Kaufman HE, Barron BA, Hill JM. Early diagnosis of infectious keratitis with in vivo real time confocal microscopy. CLAO J 1992;18:197-201
4. McHir ST, Burton M. Moorfields Eye Hospital NHS Foundation Trust. Microbial Keratitis. The Royal College of Ophthalmologists, Focus. Autumn; 2013
5. Bagyalakshmi R, Therese KL, Madhavan HN. Application of semi-nested polymerase chain reaction targeting internal transcribed spacer region for rapid detection of panfungal genome directly from ocular specimens. Indian J Ophthalmol 2007;55:261-5
6. Tananuvat N, Salakthuantee K, Vanittanakom N, Pongpom M, Ausayakhun S. Prospective comparison between conventional microbial work-up vs PCR in the diagnosis of fungal keratitis. Eye (Lond) 2012;26:1337-43
7. Borderie V, Laroche L, Chaumeil C. New strategy for rapid diagnosis and characterization of fungal infections: The example of corneal scrapings. PLoS One 2012;7:e37660. Available from: http://www.plosone.org [Last accessed on 2014 May 15]
8. Hanet MS, Jamart J, Chaves AP. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: Systematic review and meta-analysis of comparative studies. Can J Ophthalmol 2012;47:493-9
9. McLeod SD, LaBree LD, Tayyanipour R, Flowers CW, Lee PP, McDonnell PJ. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 1995;102:1943-8
10. Scoper SV. Review of third-and fourth-generation fluoroquinolones in ophthalmology: In-vitro and in-vivo efficacy. Adv Ther 2008;25:979-94
11. Solomon R, Donnenfeld ED, Perry HD, Snyder RW, Nedrud C, Stein J, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 2005;112:466-9
12. Baum J, Barza M. Topical vs subconjunctival treatment of bacterial corneal ulcers. Ophthalmology 1979;87:710-6
13. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, et al. Corticosteroids for bacterial keratitis: The Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol 2012;130:143-50
14. Alio JL, Abbouda A, Valle DD, Del Castillo JM, Fernandez JA. Corneal cross linking and infectious keratitis: A systematic review with a meta-analysis of reported cases. J Ophthalmic Inflamm Infect 2013;3:47
15. Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, et al. The mycotic ulcer treatment trial: A randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol 2013;131:422-9
16. Bunya VY, Hammersmith KM, Rapuano CJ, Ayres BD, Cohen EJ. Topical and oral voriconazole in the treatment of fungal keratitis. Am J Ophthalmol 2007;143:151-3
17. Jhanji V, Sharma N, Mannan R, Titiyal JS, Vajpayee RB. Management of tunnel fungal infection with voriconazole. J Cataract Refract Surg 2007;33:915-7
18. Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 2004;122:42-7
19. Sharma N, Chacko J, Velpandian T, Titiyal JS, Sinha R, Satpathy G, et al. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis. Ophthalmology 2013;120:677-81
20. Elder MJ, Kilvington S, Dart JK. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994;35:1059-64
21. Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance and Acanthamoeba keratitis: The quest for alternative antiprotozoal chemotherapy. Eye (Lond) 1994;8:555-63
22. Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye (Lond) 1993;7:719-25
23. Colin J. Ganciclovir ophthalmic gel, 0.15%: A valuable tool for treating ocular herpes. Clin Ophthalmol 2007;1:441-53.